Predicting Prognosis of Early-Stage Mycosis Fungoides with Utilization of Machine Learning

被引:0
|
作者
Mendi, Banu Ismail [1 ]
Sanli, Hatice [2 ]
Insel, Mert Akin [3 ]
Aydemir, Beliz Bayindir [2 ]
Atak, Mehmet Fatih [4 ]
机构
[1] Nigde Omer Halisdemir Univ Training & Res Hosp, Dept Dermatol, TR-51000 Nigde, Turkiye
[2] Ankara Univ, Fac Med, Dept Hematol, TR-06620 Ankara, Turkiye
[3] Yildiz Tech Univ, Dept Chem Engn, Istanbul 34220, Turkiye
[4] New York Med Coll, Dept Dermatol, Valhalla, NY 10595 USA
来源
LIFE-BASEL | 2024年 / 14卷 / 11期
关键词
machine learning; mycosis fungoides; prognosis; FOLD CROSS-VALIDATION; LYMPHOMA TASK-FORCE; SEZARY-SYNDROME; INTERNATIONAL-SOCIETY; EUROPEAN-ORGANIZATION; CUTANEOUS-LYMPHOMAS; COX REGRESSION; UNITED-STATES; INDEX CLIPI; SURVIVAL;
D O I
10.3390/life14111371
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mycosis fungoides (MF) is the most prevalent type of cutaneous T cell lymphomas. Studies on the prognosis of MF are limited, and no research exists on the potential of artificial intelligence to predict MF prognosis. This study aimed to compare the predictive capabilities of various machine learning (ML) algorithms in predicting progression, treatment response, and relapse and to assess their predictive power against that of the Cox proportional hazards (CPH) model in patients with early-stage MF. The data of patients aged 18 years and over who were diagnosed with early-stage MF at Ankara University Faculty of Medicine Hospital from 2006 to 2024 were retrospectively reviewed. ML algorithms were utilized to predict complete response, relapse, and disease progression using patient data. Of the 185 patients, 94 (50.8%) were female, and 91 (49.2%) were male. Complete response was observed in 114 patients (61.6%), while relapse and progression occurred in 69 (37.3%) and 54 (29.2%) patients, respectively. For predicting progression, the Support Vector Machine (SVM) algorithm demonstrated the highest success rate, with an accuracy of 75%, outperforming the CPH model (C-index: 0.652 for SVM vs. 0.501 for CPH). The most successful model for predicting complete response was the Ensemble model, with an accuracy of 68.89%, surpassing the CPH model (C-index: 0.662 for the Ensemble model vs. 0.543 for CPH). For predicting relapse, the decision tree classifier showed the highest performance, with an accuracy of 78.17%, outperforming the CPH model (C-index: 0.782 for the decision tree classifier vs. 0.505 for CPH). The results suggest that ML algorithms may be useful in predicting prognosis in early-stage MF patients.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Early-stage Mycosis Fungoides: Epidemiology and Prognosis
    Maguire, Andrew
    Puelles, Jorge
    Raboisson, Patrick
    Chavda, Rajeev
    Gabriel, Sylvie
    Thornton, Susan
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [2] New insights on treatment utilization and outcomes in early-stage mycosis fungoides
    Porcu, P.
    Nikbakht, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (04) : 594 - 595
  • [3] miRNA Signature in Early-stage Mycosis Fungoides
    Sorensen, Sissel T.
    Litman, Thomas
    Gluud, Maria
    Celis, Pamela
    Torres-Rusillo, Sara
    Willerslev-Olsen, Andreas
    Odum, Niels
    Iversen, Lars
    Lindahl, Lise M.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [4] miRNA signature in early-stage mycosis fungoides
    Sorensen, Sissel T.
    Litman, Thomas
    Gluud, Maria
    Celis, Pamela
    Torres-Rusillo, Sara
    Willerslev-Olsen, Andreas
    Odum, Niels
    Iversen, Lars
    Lindahl, Lise M.
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S4 - S4
  • [5] Molecular Markers of Early-Stage Mycosis Fungoides
    Zhang, Yaohua
    Wang, Yang
    Yu, Richard
    Huang, Yuanshen
    Su, Mingwan
    Xiao, Cheng
    Martinka, Magdalena
    Dutz, Jan P.
    Zhang, Xuejun
    Zheng, Zhizhong
    Zhou, Youwen
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (06) : 1698 - 1706
  • [6] Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides
    Lewis, Daniel J.
    Duvic, Madeleine
    DERMATOLOGIC THERAPY, 2017, 30 (03)
  • [7] Cost of early-stage mycosis fungoides treatments in Spain
    Luis Ortiz-Romero, Pablo
    Servitje, Octavio
    Teresa Estrach, Maria
    Maria Izu-Belloso, Rosa
    Fernandez-de-Misa, Ricardo
    Gallardo, Fernando
    Gonzalez, Maria-Eugenia
    Forn, Ian
    Lopez-Martinez, Noemi
    Perez-Mitru, Alejandro
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : S30 - S30
  • [8] EARLY-STAGE MYCOSIS FUNGOIDES: INCIDENCE AND DIFFERENTIAL SURVIVAL
    Maguire, A.
    Puelles, J.
    Raboisson, P.
    Chavda, R.
    Gabriel, S.
    Thornton, S.
    VALUE IN HEALTH, 2019, 22 : S906 - S906
  • [9] Mass Cytometric Analysis of Early-Stage Mycosis Fungoides
    Guo, Nannan
    Jia, Li
    Out-Luiting, Coby
    de Miranda, Noel F. C. C.
    Willemze, Rein
    Koning, Frits
    Vermeer, Maarten
    Quint, Koen
    CELLS, 2022, 11 (07)
  • [10] Cost of early-stage mycosis fungoides treatments in Spain
    Luis Ortiz-Romero, Pablo
    Servitje, Octavio
    Teresa Estrach, Maria
    Maria Izu-Belloso, Rosa
    Fernandez-de-Misa, Ricardo
    Gallardo, Fernando
    Lopez-Martinez, Noemi
    Perez-Mitru, Alejandro
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 91 - 105